| Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes JA Dubovsky, KA Beckwith, G Natarajan, JA Woyach, S Jaglowski, ... Blood, The Journal of the American Society of Hematology 122 (15), 2539-2549, 2013 | 862 | 2013 |
| Post-transplantation cyclophosphamide-based graft-versus-host disease prophylaxis J Bolaños-Meade, M Hamadani, J Wu, MM Al Malki, MJ Martens, ... New England Journal of Medicine 388 (25), 2338-2348, 2023 | 220 | 2023 |
| Clinical activity of axicabtagene ciloleucel in adult patients with Richter syndrome AS Kittai, DA Bond, B William, A Saad, S Penza, Y Efebera, K Larkin, ... Blood Advances 4 (19), 4648-4652, 2020 | 68 | 2020 |
| MicroRNA-29b mediates altered innate immune development in acute leukemia BL Mundy-Bosse, SD Scoville, L Chen, K McConnell, HC Mao, EH Ahmed, ... The Journal of clinical investigation 126 (12), 4404-4416, 2016 | 64 | 2016 |
| Selective targeting of NAMPT by KPT-9274 in acute myeloid leukemia SR Mitchell, K Larkin, NR Grieselhuber, TH Lai, M Cannon, S Orwick, ... Blood advances 3 (3), 242-255, 2019 | 56 | 2019 |
| Post-transplant cyclophosphamide, tacrolimus, and mycophenolate mofetil as the new standard for graft-versus-host disease (GVHD) prophylaxis in reduced intensity conditioning … SG Holtan, M Hamadani, J Wu, MM Al Malki, L Runaas, H Elmariah, ... Blood 140 (Supplement 2), LBA-4-LBA-4, 2022 | 54 | 2022 |
| Selinexor in combination with decitabine in patients with acute myeloid leukemia: results from a phase 1 study B Bhatnagar, Q Zhao, AS Mims, S Vasu, GK Behbehani, K Larkin, ... Leukemia & lymphoma 61 (2), 387-396, 2020 | 44 | 2020 |
| Targeting BTK through microRNA in chronic lymphocytic leukemia A Bottoni, L Rizzotto, TH Lai, C Liu, LL Smith, R Mantel, S Reiff, ... Blood, The Journal of the American Society of Hematology 128 (26), 3101-3112, 2016 | 44 | 2016 |
| Outcome prediction by the 2022 European LeukemiaNet genetic-risk classification for adults with acute myeloid leukemia: an Alliance study K Mrózek, J Kohlschmidt, JS Blachly, D Nicolet, AJ Carroll, KJ Archer, ... Leukemia 37 (4), 788-798, 2023 | 36 | 2023 |
| PP2A is a therapeutically targetable driver of cell fate decisions via a c-Myc/p21 axis in human and murine acute myeloid leukemia S Goswami, R Mani, J Nunes, CL Chiang, K Zapolnik, E Hu, F Frissora, ... Blood, The Journal of the American Society of Hematology 139 (9), 1340-1358, 2022 | 27* | 2022 |
| High early death rates, treatment resistance, and short survival of Black adolescents and young adults with AML KT Larkin, D Nicolet, BJ Kelly, K Mrózek, S LaHaye, KE Miller, S Wijeratne, ... Blood advances 6 (19), 5570-5581, 2022 | 22 | 2022 |
| Cytopenias after chimeric antigen receptor T-cells (CAR-T) infusion; patterns and outcomes A Schaefer, C Saygin, J Maakaron, T Hoelscher, Z Purdin, J Robinson, ... Biology of Blood and Marrow Transplantation 25 (3), S171, 2019 | 22 | 2019 |
| Novel therapies in AML: reason for hope or just hype? K Larkin, W Blum American Society of Clinical Oncology Educational Book 34 (1), e341-e351, 2014 | 17 | 2014 |
| Transducin b-like protein 1 controls multiple oncogenic networks in diffuse large B-cell lymphoma Y Youssef, V Karkhanis, WK Chan, F Jeney, A Canella, X Zhang, S Sloan, ... haematologica 106 (11), 2927, 2021 | 13 | 2021 |
| Incidence of venous thrombosis after peg-asparaginase in adolescent and young adults with acute lymphoblastic leukemia B Underwood, Q Zhao, AR Walker, AS Mims, S Vasu, M Long, T Z. Haque, ... International Journal of Hematologic Oncology 9 (3), IJH28, 2020 | 13 | 2020 |
| Acute GVHD, BK virus hemorrhagic cystitis and age are risk factors for transplant-associated thrombotic microangiopathy in adults S Vasu, M Bostic, Q Zhao, N Sharma, M Puto, S Knight, D Scott, ... Blood Advances 6 (4), 1342-1349, 2022 | 12 | 2022 |
| Effect of early post-transplantation tacrolimus concentration on the risk of acute graft-versus-host disease in allogenic stem cell transplantation N Sharma, Q Zhao, B Ni, P Elder, M Puto, DM Benson, A Rosko, ... Cancers 13 (4), 613, 2021 | 12 | 2021 |
| Sex-associated differences in frequencies and prognostic impact of recurrent genetic alterations in adult acute myeloid leukemia (Alliance, AMLCG) M Ozga, D Nicolet, K Mrózek, AS Yilmaz, J Kohlschmidt, KT Larkin, ... Leukemia 38 (1), 45-57, 2024 | 11 | 2024 |
| Loss of expression of both miR-15/16 loci in CML transition to blast crisis F Lovat, P Gasparini, G Nigita, K Larkin, JC Byrd, MD Minden, M Andreeff, ... Proceedings of the National Academy of Sciences 118 (11), e2101566118, 2021 | 9 | 2021 |
| Antagonizing ClpP: a new power play in targeted therapy for AML K Larkin, JC Byrd Cancer Cell 27 (6), 747-749, 2015 | 9 | 2015 |
Sumithira VasuProfessor of Medicine, The Ohio State University在 osu.edu 的电子邮件经过验证
